Early Stage Testicular Cancer - Surveillance Is Best Follow-Up Strategy
A long-term study of men with stage I seminoma, a common form of testicular cancer, suggests that surveillance for cancer recurrence, rather than additional chemotherapy or radiation therapy, is sufficient for the vast majority of patients who have undergone successful surgery for their cancer. In a new long-term study conducted in Denmark, researchers analyzed a national clinical database and found that 99.6% of patients who only underwent surveillance (following a successful surgery) were alive after 10 years of being diagnosed with testicular cancer... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 17, 2013 Category: Consumer Health News Tags: Urology / Nephrology Source Type: news
ASCO: Surveillance for Early Seminoma Found Safe
CHICAGO (MedPage Today) -- Most men with stage I seminoma can safely enter surveillance and avoid unnecessary therapy without jeopardizing survival, according to data from a large registry. (Source: MedPage Today Surgery)
Source: MedPage Today Surgery - May 16, 2013 Category: Surgery Source Type: news
Surveillance Sufficient After Surgery in Early SeminomaSurveillance Sufficient After Surgery in Early Seminoma
Survival after surgery in stage I seminoma is excellent, and new data show that surveillance is sufficient for most patients. Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 16, 2013 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Postsurgical surveillance sufficient for men with stage I seminoma
(Source: HemOncToday.com)
Source: HemOncToday.com - May 16, 2013 Category: Cancer & Oncology Source Type: news
Excess deaths among seminoma patients persist
US research shows that men diagnosed with stage I seminoma since the advent of contemporary radiotherapy have a significantly increased risk for all-cause mortality compared with the overall population, despite being unlikely to die from testicular cancer itself. (Source: MedWire News - Urology)
Source: MedWire News - Urology - May 13, 2013 Category: Urology & Nephrology Source Type: news
Excess deaths among seminoma patients persist
US research shows that men diagnosed with stage I seminoma since the advent of contemporary radiotherapy have a significantly increased risk for all-cause mortality compared with the overall population, despite being unlikely to die from testicular cancer itself. (Source: MedWire News - Oncology)
Source: MedWire News - Oncology - May 13, 2013 Category: Cancer & Oncology Source Type: news
Novel gene mutation identified that predisposes to testicular cancer
Researchers at the University Medical Center (UMC) Utrecht, the Netherlands, have identified a novel gene mutation that predisposes to seminoma, the most common form of testicular cancer in young men. (Source: Pharmacy Europe)
Source: Pharmacy Europe - April 12, 2013 Category: Drugs & Pharmacology Source Type: news
